.Operating system Therapies will definitely specify on the NYSE American sell swap this morning by m...
.ALX Oncology's period 2 stomach cancer action cost has actually diminished. After seeing its own CD...
.Another of Ionis Pharmaceuticals' crucial midphase readouts has fallen short of assumptions, motiva...
.While Biogen's pharma peers are actually seeking for late-stage assets along with little threat, CE...
.Instil Bio has actually been actually a biotech trying to find a pipeline after it junked its lead ...
.Biogen has actually handed back legal rights to an early Alzheimer's illness program to Denali Ther...
.Invite to today's Chutes & Ladders, our roundup of considerable management hirings, shootings as...
.Vertex's attempt to handle an unusual genetic health condition has hit another drawback. The biotec...
.Vir Biotechnology's second-quarter incomes document wasn't except major updates. The company accept...
.Galapagos has stopped briefly application in a trial of a BCMA-directed CAR-T cell therapy, pushing...